ABACTAGON Trademark

Trademark Overview

On Tuesday, January 15, 2008, a trademark application was filed for ABACTAGON with the United States Patent and Trademark Office. The USPTO has given the ABACTAGON trademark a serial number of 77372142. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 26, 2011. This trademark is owned by Glaxo Group Limited. The ABACTAGON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
abactagon

General Information

Serial Number77372142
Word MarkABACTAGON
Filing DateTuesday, January 15, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 26, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Tuesday, December 27, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 26, 2011ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2011EXTENSION 5 GRANTED
Monday, April 18, 2011EXTENSION 5 FILED
Monday, April 18, 2011TEAS EXTENSION RECEIVED
Friday, October 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 21, 2010EXTENSION 4 GRANTED
Wednesday, October 13, 2010EXTENSION 4 FILED
Wednesday, October 13, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2010EXTENSION 3 GRANTED
Friday, April 9, 2010EXTENSION 3 FILED
Friday, April 9, 2010TEAS EXTENSION RECEIVED
Tuesday, November 10, 2009EXTENSION 2 GRANTED
Thursday, October 22, 2009EXTENSION 2 FILED
Tuesday, November 10, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 22, 2009TEAS EXTENSION RECEIVED
Tuesday, October 20, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 23, 2009EXTENSION 1 GRANTED
Thursday, April 23, 2009EXTENSION 1 FILED
Thursday, April 23, 2009TEAS EXTENSION RECEIVED
Wednesday, April 22, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 22, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 25, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 2, 2008PUBLISHED FOR OPPOSITION
Wednesday, August 13, 2008NOTICE OF PUBLICATION
Wednesday, July 30, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 30, 2008ASSIGNED TO LIE
Tuesday, July 29, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 22, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 23, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 23, 2008NON-FINAL ACTION E-MAILED
Wednesday, April 23, 2008NON-FINAL ACTION WRITTEN
Monday, April 21, 2008ASSIGNED TO EXAMINER
Friday, January 18, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

abactagon pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic